Plasmid DNA
BIO
Innovative viral vector vaccine services: Delivered with certainty
From early clinical to late-stage commercial, ReciBioPharm’s comprehensive vaccine development and manufacturing solutions are designed with the operational excellence needed to reliably deliver your viral vector vaccine to patients.
Reliable viral vector vaccine development and manufacturing
With our broad cell line experience — including VERO, HEK293 and A549 — backed by adherent and suspension cell cultivation and egg-based systems, you can rely on us to meet your viral vector vaccine needs. Our flexible and tailored approach enables reliable support across the entire life cycle of your product.
Supporting virus types, including:
- Adenovirus (human and NHP)
- Respiratory syncytial virus (RSV)
- Newcastle disease (NDV)
- Influenza (Flu)
- Dengue (DENV)
- Infectious bursal disease (IBDV)
- Infectious bronchitis virus (IBV)
- Measles (rubeola)
- Poxviruses (MVA, Fowlpox)
Meeting evolving needs with specialised expertise
We have supported customers with comprehensive vaccine development and vaccine contract manufacturing for therapeutic and prophylactic use with uncompromised quality.
Using dynamic expertise, our diverse global team provides the scientific know-how to de-risk projects. At the same time, our specialist capabilities can meet the evolving needs of your viral vector vaccine as it progresses through its life cycle.
Our viral vector vaccine services
- In-house plasmid manufacturing
- Helper virus infection/transduction processes
- RCB generation
- Adaptation to suspension or to serum-free
- Producer cell line systems (adherent and suspension supported)
- Optimization of productivity for cell and egg-based production
- Established platform manufacturing unit operations
- Platform analytical methods for quality control
- Aseptic fill and finish services
Want to know more about our full biologics service offering?